Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual
Christos P Kotanidis1,2, Gregory B Mills1,2, Bjørn Bendz3,4
1Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, 4th Floor William Leech Building, Newcastle upon Tyne NE2 4HH, UK.
Routine invasive treatment for older patients with non-ST-elevation acute coronary syndrome (NSTEACS) did not reduce overall mortality or myocardial infarction (MI) risk. However, it significantly lowered the risk of repeat MI and urgent revascularization.
Area of Science:
- Cardiology
- Geriatric Medicine
- Interventional Cardiology
Background:
- Older patients with non-ST-elevation acute coronary syndrome (NSTEACS) often receive less guideline-recommended care.
- Evidence on interventional management strategies for elderly NSTEACS patients is limited.
- This study addresses the scarcity of data on invasive vs. conservative strategies in this population.
Purpose of the Study:
- To assess the impact of routine invasive versus conservative management in older patients (>70 years) with NSTEACS.
- Utilized individual patient data (IPD) from randomized controlled trials (RCTs).
- Evaluated the primary endpoint of all-cause mortality and myocardial infarction (MI) at 1 year.
Main Methods:
- Systematic literature search of MEDLINE, Web of Science, and Scopus (2010-2023).
- Included RCTs comparing routine invasive and conservative strategies in NSTEACS patients >70 years.
- Employed one-stage IPD meta-analysis using random-effects and fixed-effect Cox models.
Main Results:
- Six RCTs with 1479 participants were analyzed.
- No significant difference in the composite endpoint of all-cause mortality and MI at 1 year (HR 0.87, P=.43).
- Significantly lower hazard for MI (HR 0.62, P=.006) and urgent revascularization (HR 0.41, P=.037) in the invasive group.
Conclusions:
- Routine invasive treatment for NSTEACS in older adults does not reduce 1-year all-cause mortality or MI composite risk.
- Invasive management significantly reduces the risk of repeat MI and the need for urgent revascularization.
- Further research from ongoing large clinical trials is warranted.
More Related Videos
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
09:21Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
